Delivery Order SPE2DR25D1205-SPE2DR26F1AB9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) on November 17, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs,...
- The Defense Logistics Agency awarded a $7,352.49 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of Erleada 240 mg tablets, with a completion date of November 24, 2025. This non-set-aside, firm fixed-price contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Erleada 60 mg tablets (120-count units) valued at $7,965.80, with completion scheduled for February 5, 2026. This firm fixed-price contract award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.79 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) on October 29, 2025, with completion scheduled for November 20, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $15,931.60 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Erleada 60 mg tablets in quantities of 120 units. This is a firm fixed-price contract with an ultimate completion date of January 26, 2026, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate office and serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Erleada 60 mg tablets (120-count units) with a ceiling value of $7,965.80. This firm fixed-price delivery order is set to complete by December 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's continued capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units, with a contract ceiling value of $7,352.49. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, was competitively awarded without set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Erleada 240 mg tablets (30-unit packages) valued at $14,704.98. This competitively awarded, firm fixed-price contract carries an ultimate completion date of October 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $7,748.39 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, represents a firm fixed price transaction utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AB9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,965.80 to Amerisourcebergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) with a completion date of February 9, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is executed under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables the contractor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract structure reflects DLA's reliance on Amerisourcebergen as a critical partner in maintaining pharmaceutical supply chain operations for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 1/15/26 |